BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10535568)

  • 1. Differential expression of CD34 and Ki-M1p in pleomorphic fibroma and dermatofibroma with monster cells.
    Rudolph P; Schubert C; Zelger BG; Zelger B; Parwaresch R
    Am J Dermatopathol; 1999 Oct; 21(5):414-9. PubMed ID: 10535568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of immunohistochemistry in atypical cutaneous fibrous histiocytoma.
    Wilk M; Zelger BG; Nilles M; Zelger B
    Am J Dermatopathol; 2004 Oct; 26(5):367-71. PubMed ID: 15365367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34.
    Mahmood MN; Salama ME; Chaffins M; Ormsby AH; Ma CK; Linden MD; Lee MW
    J Cutan Pathol; 2003 Nov; 30(10):631-6. PubMed ID: 14744088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotyping of dermal spindle cell tumors: diagnostic value of monocyte marker Ki-M1p and histogenetic considerations.
    Rudolph P; Schubert B; Wacker HH; Parwaresch R; Schubert C
    Am J Surg Pathol; 1997 Jul; 21(7):791-800. PubMed ID: 9236835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
    Goldblum JR; Tuthill RJ
    Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
    Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
    Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
    Abenoza P; Lillemoe T
    Am J Dermatopathol; 1993 Oct; 15(5):429-34. PubMed ID: 7694515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dermatofibroma: co-existence of two or more variant patterns in a single lesion.
    Zelger BG; Sidoroff A; Zelger B
    Histopathology; 2000 Jun; 36(6):529-39. PubMed ID: 10849095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotic fibroma-like dermatofibroma: an uncommon distinctive variant of dermatofibroma.
    González-Vela MC; Val-Bernal JF; Martino M; González-López MA; García-Alberdi E; Hermana S
    Histol Histopathol; 2005 Jul; 20(3):801-6. PubMed ID: 15944929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas.
    Prieto VG; Reed JA; Shea CR
    J Cutan Pathol; 1995 Aug; 22(4):336-41. PubMed ID: 7499573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous dermatofibroma showing a depressed surface.
    Chang SE; Choi JH; Sung KJ; Moon KC; Koh JK
    Int J Dermatol; 2001 Jan; 40(1):77-8. PubMed ID: 11277963
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N; McNiff J; Hui P; Manfioletti G; Tallini G
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoid dermatofibrohistiocytoma: an indolent post-traumatic tumor composed of CD34+ epithelioid and dendritic cells and factor XIIIa+ dendrophages.
    Silverman JS; Brustein S
    J Cutan Pathol; 1996 Dec; 23(6):551-7. PubMed ID: 9001986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34-reactive myxoid dermal dendrocytoma.
    Ohata C; Kawahara K
    Am J Dermatopathol; 2002 Feb; 24(1):50-3. PubMed ID: 11803282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
    Cohen PR; Rapin RP; Farhood AI
    Am J Dermatopathol; 1994 Oct; 16(5):573-4. PubMed ID: 7528477
    [No Abstract]   [Full Text] [Related]  

  • 17. Pleomorphic hyalinizing angiectatic tumor of soft parts: immunohistochemical case study shows cellular composition by CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Dana MM
    J Cutan Pathol; 1997 Jul; 24(6):377-83. PubMed ID: 9243366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of dermatofibroma with monster cells: a review and an immunohistochemical study.
    Setoyama M; Fukumaru S; Kanzaki T
    Am J Dermatopathol; 1997 Jun; 19(3):312-5. PubMed ID: 9185923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subungual myxoid pleomorphic fibroma.
    Hassanein A; Telang G; Benedetto E; Spielvogel R
    Am J Dermatopathol; 1998 Oct; 20(5):502-5. PubMed ID: 9790115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of CD34-positive dendritic cells of human dermis.
    Narvaez D; Kanitakis J; Faure M; Claudy A
    Am J Dermatopathol; 1996 Jun; 18(3):283-8. PubMed ID: 8806963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.